Disclosure Of Fair Value Measurement [Text Block]

Innate Pharma - Filing #2811003

Concept As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
184 193 EUR
207 863 EUR
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
495,000 EUR
51 901 EUR
329 323 EUR
7 570 EUR
384 255 EUR
4 044 EUR
54 151 EUR
819,000 EUR
58 103 EUR
379 637 EUR
272 213 EUR
4 011 EUR
219 404 EUR
107 440 EUR
52 809 EUR
456,000 EUR
375 220 EUR
3 978 EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.